Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria-Reference-Cited by-同舟云学术

Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria

Published:2022-03 Issue: Volume:30 Page:100846
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Ranganath L.R.,Milan A.M.,Hughes A.T.,Davison A.S.,Khedr M.,Norman B.P.,Bou-Gharios G.,Gallagher J.A.,Gornall M.,Jackson R.,Imrich R.,Rovensky J.,Rudebeck M.,Olsson B.

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference29 articles.

1. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584–1962);O’Brien;Am. J. Med.,1963

2. Natural history of alkaptonuria;Phornphutkul;N. Engl. J. Med.,2002

3. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria;Introne;Mol. Genet. Metab.,2011

4. Nitisinone arrests ochronosis and decreases rate of progression of alkaptonuria: evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre;Ranganath;Mol. Genet. Metab.,2018

5. First treatment for rare metabolic disorder alkaptonuria. https://www.ema.europa.eu/en/news/first-treatment-raremetabolic-disorder-alkaptonuria. Accessed December 1, 2021.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria;Current Protein & Peptide Science;2023-06

2. Metabolic profiles and fingerprints for the investigation of the influence of nitisinone on the metabolism of the yeast Saccharomyces cerevisiae;Scientific Reports;2023-01-26

3. Untargeted NMR Metabolomics Reveals Alternative Biomarkers and Pathways in Alkaptonuria;International Journal of Molecular Sciences;2022-12-13

4. Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria;Metabolites;2022-09-29

5. Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria;Scientific Reports;2022-09-27